论文部分内容阅读
目的探讨低分子肝素钙治疗不稳定型心绞痛(UAP)的临床治疗效果。方法本样本回顾分析2008年1月至2009年6月收治的76例UAP采用不同方法治疗的临床资料。结果两组治疗后心绞痛发作次数均有减少,观察组有效率94.74%明显高于对照组的73.68%,差异有显著性。低分子肝素钙注射后有15.79%患者出现注射部位轻度皮下瘀斑,但均不影响治疗,无出现出血倾向。两组药物不良反应差别不明显,无统计学意义。结论低分子肝素钙治疗UAP疗效显著,无严重出血病例等不良反应,使用安全方便,值得临床进一步推广使用。
Objective To investigate the clinical effect of low molecular weight heparin on unstable angina pectoris (UAP). Methods This sample was retrospectively analyzed from January 2008 to June 2009, 76 cases of UAP treated with different methods of clinical data. Results The number of angina attacks decreased after treatment in both groups. The effective rate in the observation group was 94.74%, which was significantly higher than that in the control group (73.68%), the difference was significant. Low molecular weight heparin injection after injection of 15.79% of patients with mild subcutaneous ecchymosis, but did not affect the treatment, no bleeding tendency. Two groups of adverse drug reactions did not differ significantly, no statistical significance. Conclusion Low molecular weight heparin treatment of UAP significant effect, no serious adverse reactions such as bleeding cases, the use of safe and convenient, it is worth further clinical use.